GNRH1 and ovarian hyperstimulation syndrome: The use of the GnRH antagonist protocol, combined with the GnRH agonist trigger, and the freeze-all policy are recommended for the prevention of ovarian hyperstimulation syndrome (OHSS) (2–4).